PLEOMORPHIC LIPOSARCOMA
Clinical trials for PLEOMORPHIC LIPOSARCOMA explained in plain language.
Never miss a new study
Get alerted when new PLEOMORPHIC LIPOSARCOMA trials appear
Sign up with your email to follow new studies for PLEOMORPHIC LIPOSARCOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Proton beams take aim at inoperable sarcomas in new trial
Disease control Recruiting nowThis study tests whether a higher dose of proton radiation can better control soft tissue sarcomas that cannot be surgically removed. About 40 adults in Norway will receive radiation over 4 weeks, with the highest dose focused on the tumor center. Researchers will also look at bl…
Matched conditions: PLEOMORPHIC LIPOSARCOMA
Phase: PHASE2 • Sponsor: Oslo University Hospital • Aim: Disease control
Last updated May 15, 2026 11:53 UTC
-
New combo therapy aims to halt rare cancer growth
Disease control Recruiting nowThis study tests whether two drugs, mirdametinib and palbociclib, can safely control advanced liposarcoma that has spread or cannot be removed by surgery. About 54 adults with this rare cancer will receive different doses to find the best balance of safety and effectiveness. The …
Matched conditions: PLEOMORPHIC LIPOSARCOMA
Phase: PHASE1, PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated May 15, 2026 11:53 UTC
-
New hope for rare sarcomas: immune drug plus chemo tested
Disease control Recruiting nowThis study tests whether adding the immunotherapy drug tislelizumab to standard chemotherapy can help shrink or control advanced soft tissue sarcomas that cannot be removed by surgery. About 45 adults aged 18-75 with certain sarcoma types will receive the combination as their fir…
Matched conditions: PLEOMORPHIC LIPOSARCOMA
Phase: PHASE2 • Sponsor: Fudan University • Aim: Disease control
Last updated May 13, 2026 16:03 UTC